Columbia University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1754-01-01
- Employees
- 20.8K
- Market Cap
- -
Ablation Guided Via Precision Imaging Using Electromechanical Wave Imaging
Not Applicable
- Conditions
- Arrhythmias, Cardiac
- Interventions
- Diagnostic Test: Electromechanical wave imaging (EWI)
- First Posted Date
- 2024-08-29
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 322
- Registration Number
- NCT06577714
- Locations
- 🇺🇸
Columbia University, New York, New York, United States
A Study of Gemcitabine/Cisplatin Plus Cemiplimab (REGN2810, Anti-PD-1) With or Without Fianlimab (REGN3767, Anti-LAG-3) in Patients With Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)
Phase 2
Not yet recruiting
- Conditions
- Muscle-Invasive Bladder CarcinomaBladder Cancer
- Interventions
- First Posted Date
- 2024-08-26
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 36
- Registration Number
- NCT06571708
- Locations
- 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States
The Sleep2BWell Trial
Not Applicable
Active, not recruiting
- Conditions
- Diet, HealthyWeight LossPhysical ActivityBlood PressureSleep Health
- Interventions
- Behavioral: Multidimensional Sleep Health SessionsBehavioral: Healthy Diet SessionsBehavioral: Physical Activity Sessions
- First Posted Date
- 2024-08-21
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 210
- Registration Number
- NCT06565104
- Locations
- 🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇺🇸Columbia University Irving Medical Center, Mailman School of Public Health, New York, New York, United States
Human Models of Selective Insulin Resistance: Pancreatic Clamp
Phase 1
Not yet recruiting
- Conditions
- Insulin ResistanceHyperinsulinemiaMetabolic Dysfunction Associated Steatotic Liver DiseaseNon-Alcoholic Fatty Liver DiseasePrediabetic StateObesity
- Interventions
- Drug: Growth Hormone, HumanDiagnostic Test: [6,6-2H2] D-glucoseDiagnostic Test: [1-13C1] sodium acetateDietary Supplement: Nestle BOOST PlusDietary Supplement: KIND BarDevice: Harvard Apparatus PHD ULTRA CP syringe pumpDevice: Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer
- First Posted Date
- 2024-08-16
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 36
- Registration Number
- NCT06558422
- Locations
- 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States
Effects of tDCS and VNS on Postoperative Analgesia
Not Applicable
Not yet recruiting
- Conditions
- Acute Postoperative Pain
- Interventions
- Other: Sham transcranial direct current stimulationDevice: Active transcranial direct current stimulationDevice: Active vagus nerve stimulationOther: Sham vagus nerve stimulation
- First Posted Date
- 2024-08-14
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 200
- Registration Number
- NCT06554067
Medically Tailored Meals for Cardiovascular Health Equity
Not Applicable
Recruiting
- Conditions
- Diet, HealthyHbA1cBlood Pressure
- Interventions
- Behavioral: Medically Tailored Meals and Nutritional CounselingBehavioral: Cardiovascular Health Promotion Educational Program
- First Posted Date
- 2024-08-13
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 200
- Registration Number
- NCT06550297
- Locations
- 🇺🇸
Columbia University Mailman School of Public Health, New York, New York, United States
Prediction of Anxiety and Memory State
Recruiting
- Conditions
- AnxietyEpilepsyMemory
- Interventions
- Other: CAMERA (Context-Aware Multimodal Ecological Research and Assessment)
- First Posted Date
- 2024-08-13
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 40
- Registration Number
- NCT06551090
- Locations
- 🇺🇸
Columbia University, New York, New York, United States
Engaging Patients in Adherence Interventions Using Behavioral Science
Not Applicable
Active, not recruiting
- Conditions
- Uncontrolled Hypertension
- Interventions
- Behavioral: Control recruitment letterBehavioral: Primer postcardBehavioral: Behavioral theory-informed recruitment letterBehavioral: 4 phone callsBehavioral: 2 phone calls
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 584
- Registration Number
- NCT06543394
- Locations
- 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States
A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus
Phase 1
Recruiting
- Conditions
- Systemic Lupus Erythematosus
- Interventions
- Biological: NKX019
- First Posted Date
- 2024-07-24
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 6
- Registration Number
- NCT06518668
- Locations
- 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States
PiMZ Longitudinal Cohort (PiMZ Logic)
Not yet recruiting
- Conditions
- Alpha 1-Antitrypsin DeficiencyEmphysema or COPD
- First Posted Date
- 2024-07-17
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 80
- Registration Number
- NCT06505603
- Locations
- 🇺🇸
University of California- Los Angeles, Los Angeles, California, United States
🇺🇸Columbia University, New York, New York, United States
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States
© Copyright 2025. All Rights Reserved by MedPath